Trump makes sweeping HIV research and grant cuts: ‘setting us back decades’
Published by EATG
A source is testimony, not proof. Citing one is a provenance fact — it records who said what, where — and never a verification that the claim is true.
Who is named
The characters and things this document talks about — 11 in alls. Each links to everything else the record knows about them.
Organisations 3
Claims made
Every claim in this document. Firsthand = asserted on its own basis; secondhand = recounted from elsewhere, carrying no independent weight.
-
The U.S. federal government cancelled dozens of grants to study HIV prevention and care.
The federal government has cancelled dozens of grants to study how to prevent new HIV infections and expand access to care, decimating progress toward eliminating the epidemic in the United States, scientists say.
-
The National Institutes of Health (NIH) terminated at least 145 grants related to researching advancements in HIV care that had been awarded nearly $450m in federal funds.
-
“The loss of this research could very well result in a resurgence of HIV that becomes more generalized in this country,” said Julia Marcus, a professor at Harvard Medical School who recently had two of her grants cancelled.
-
The FDA approved pre‑exposure prophylaxis (PrEP) in 2012.
In 2012, the FDA approved pre‑exposure prophylaxis (PrEP), an antiviral drug taken once a day that is highly successful at preventing new HIV infections.
-
There are still about 30,000 new HIV infections each year in the United States.
Despite major progress, there are still 30,000 new infections each year in the US.
-
A termination letter reviewed by the Guardian dated 20 March cited that “so‑called diversity, equity and inclusion (DEI) studies are often used to support unlawful discrimination on the basis of race and other protected characteristics, which harms the health of Americans.”
-
The National Institutes of Health did not expand on why the grants were terminated in response to questions from the Guardian. In a statement it said it is “taking action to terminate research funding that is not aligned with NIH and HHS priorities.
-
Many researchers were left stunned by the scale of the cancellations since in 2019, Donald Trump announced in his State of the Union address a commitment to eliminate the HIV epidemic in the country over the next 10 years.
-
As part of this initiative, his administration negotiated a deal with drug companies to provide free PrEP for 200,000 low‑income patients.
-
Amy Nunn said she had tailored grant proposals to fit the policy goals of the initiative.
Amy Nunn, a professor at the Brown University School of Public Health, said she had even tailored grant proposals to fit the policy goals of the initiative, which included geographically targeting HIV prevention efforts.
-
Nathaniel Albright learned earlier this month that an NIH grant supporting his doctoral research was cancelled even though his project had already been completed.
-
Pamina Gorbach, an epidemiologist who teaches at University of California, Los Angeles, had been following hundreds of men living with HIV in Los Angeles for 10 years to learn their needs.
-
Gorbach said the funding was cancelled earlier this month.
“It’s really devastating,” said Gorbach, “If you’re living with HIV and you’re not on meds, you know what happens? You get sick and you die.”
-
“This is erasing an entire population of people who have been impacted by an infectious disease,” said Erin Kahle, the director of the Center for Sexuality and Health Disparities at the University of Michigan who lost an NIH grant.
-
NIH funds often make up at least a portion of university professors’ salaries.
The NIH funds also often make up at least a portion of university professor’s salaries, all said they were most alarmed by the impact on services for their patients and the loss of progress toward ending the epidemic.
No claims match this filter.
What it cost
Reading this document into the graph cost <$0.01.
15 claims in all. Content fingerprint 9d4bb706d2e3… —
the document's text itself is not republished here; follow the link above to read it at
its source.